ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory    
January - February - March - April - May - June - July - August - September - Oktober - November - December | 2002 - 2003 - 2004 - 2005 - 2006 - 2007 - 2008 - 2009 - 2010 - 2011 - 2012 - 2013 - 2014 - 2015 - 2016 - 2017 - 2018 - 2019 - 2020 - 2021 - 2022 - 2023 - 2024
April 2024 - 28 products
     Paliperidon Spirig HC
retard 25 mg/0.25 ml
 68.6791.1010 %Spirig HealthCare AGB / SL / SGGtell a friend
     Paliperidon Spirig HC
retard 50 mg/0.50 ml
 112.62138.9010 %Spirig HealthCare AGB / SL / SGGtell a friend
     Paliperidon Spirig HC
retard 75 mg/0.75 ml
 156.28186.4010 %Spirig HealthCare AGB / SL / SGGtell a friend
     Paliperidon Spirig HC
retard 100 mg/1 ml
 191.41224.6010 %Spirig HealthCare AGB / SL / SGGtell a friend
     Paliperidon Spirig HC
retard 150 mg/1.5 ml
 238.98276.3010 %Spirig HealthCare AGB / SL / SGGtell a friend
  IPCI Belasone Leman30 g4.9914.6510 %Ointment: 2 Active AgentsLeman SKL SAB / SL / SGGtell a friend
L IPCI Vildagliptin Metformin
Spirig HC 50 mg/500 mg
6020.2538.4510 %Coated tablets: 2 Active AgentsSpirig HealthCare AGB / SL / SGGtell a friend
L IPCI Vildagliptin Metformin
Spirig HC 50 mg/500 mg
18060.7682.5010 %Coated tablets: 2 Active AgentsSpirig HealthCare AGB / SL / SGGtell a friend
L IP  Vildagliptin Metformin
Spirig HC 50 mg/850 mg
6020.2538.4510 %Coated tablets: 2 Active AgentsSpirig HealthCare AGB / SL / SGGtell a friend
L IP  Vildagliptin Metformin
Spirig HC 50 mg/850 mg
18060.7682.5010 %Coated tablets: 2 Active AgentsSpirig HealthCare AGB / SL / SGGtell a friend
L IP  Vildagliptin Metformin
Spirig HC 50 mg/1000 mg
6020.2538.4510 %Coated tablets: 2 Active AgentsSpirig HealthCare AGB / SL / SGGtell a friend
L IP  Vildagliptin Metformin
Spirig HC 50 mg/1000 mg
18060.7682.5010 %Coated tablets: 2 Active AgentsSpirig HealthCare AGB / SL / SGGtell a friend
L IP  Tevimbra, 100 mg / 10 ml
Konzentrat zur
Herstellung einer
Infusionslösung
 1816.161991.6010 %Tislelizumabum 100mg / 10mlBeiGene Switzerland
GmbH
A / SLGtell a friend
L IPCI Akeega 50 mg/500 mg564741.805172.9010 %Coated tablets: 2 Active AgentsJanssen-Cilag AGA / SLGtell a friend
L IP  Akeega 100 mg/500 mg564741.805172.9010 %Coated tablets: 2 Active AgentsJanssen-Cilag AGA / SLGtell a friend
L IPCI Sogroya 5 mg/ 1.5 ml1.5 ml292.41334.4510 %Injektionslösung im Fertigpen: Somapacitanum 5mg / 1.5mlNovo Nordisk Pharma AGA / SLGtell a friend
L IP  Sogroya 10 mg/ 1.5 ml1.5 ml584.83652.4510 %Injektionslösung im Fertigpen: Somapacitanum 10mg / 1.5mlNovo Nordisk Pharma AGA / SLGtell a friend
L IP  Sogroya 15 mg/ 1.5 ml1.5 ml834.08923.5510 %Injektionslösung im Fertigpen: Somapacitanum 15mg / 1.5mlNovo Nordisk Pharma AGA / SLGtell a friend
     Similasan Graphites
compositum
20 x 0.4 mlPRPRk.A.T&S Eye Care
Management AG
DGtell a friend
  IP  Enrylaze 10 mg/vial3PRPRk.A.Injection solution: Crisantaspasum 10mg / 0.5mlMEDA Pharmaceuticals
Switzerland GmbH
AGtell a friend
  IP  Qarziba 20,25 mg/4,5 ml PRPRk.A.Concentrate for infusion: Dinutuximabum Beta 20.25mg / 4.5mlMedius AGAGtell a friend
  IP  Voydeya 100 mg168PRPRk.A.Coated tablets: Danicopanum 100 mgAlexion Pharma GmbHAGtell a friend
  IP  Voydeya 100 mg180PRPRk.A.Coated tablets: Danicopanum 100 mgAlexion Pharma GmbHAGtell a friend
  IPCI Voydeya 50 mg / 100 mg168PRPRk.A.Coated tablets: Danicopanum 50 mg
Coated tablets: Danicopanum 100 mg
Alexion Pharma GmbHAGtell a friend
  IPCI Voydeya 50 mg / 100 mg180PRPRk.A.Coated tablets: Danicopanum 50 mg
Coated tablets: Danicopanum 100 mg
Alexion Pharma GmbHAGtell a friend
     Bijuva 1 mg / 100 mg28PRPRk.A.Soft capsules: 2 Active AgentsFuture Health Pharma
GmbH
BGtell a friend
     Similasan Beanspruchte
Augen
20PRPRk.A.Augentropfen Monodosen: 5 Active AgentsT&S Eye Care
Management AG
DGtell a friend
     Rocuronium Aguettant 10
mg/ml
10 x 5 mlPRPRk.A.solution injectable en seringue préremplie: Rocuronii Bromidum 50mg / 5mlAguettant Suisse SABGtell a friend
 show caption
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home